Serotonergic psychedelics as potential therapeutics for post-COVID-19 syndrome (or Long COVID): A comprehensive review.
Progress in Neuro-Psychopharmacology and Biological Psychiatry March 20, 2025 Zhen Xuen Brandon Low, Shin Jie Yong, Hayam A Alrasheed et al.
In our ongoing battle against the coronavirus 2019 (COVID-19) pandemic, a major challenge is the enduring symptoms that continue after acute infection. Also known as Long COVID, post-COVID-19 syndrome (PCS) often comes with debilitating symptoms like fatigue, disordered sleep, olfactory dysfunction, and cognitive issues ("brain fog"). Currently, there are no approved treatments for PCS. Recent...
DOI: 10.1016/j.pnpbp.2025.111279 (opens in new tab)
Full text (opens in new tab)
Neuroplasticity
Serotonin
Inflammation
Long covid
+2